英国世界首例试验药物治愈肺癌病人

2017-03-13 佚名 科技部

英国曼彻斯特克里斯蒂医院近日宣布,一位肺癌晚期患者(癌细胞已扩散到淋巴结)在采用了该医院的一种试验药物后,其癌细胞影像已完全消失。一年前,在传统标准治疗手段对患者已经没有任何作用后,该患者接受了世界首例人体采用这一测试药物的治疗。

英国曼彻斯特克里斯蒂医院近日宣布,一位肺癌晚期患者(癌细胞已扩散到淋巴结)在采用了该医院的一种试验药物后,其癌细胞影像已完全消失。一年前,在传统标准治疗手段对患者已经没有任何作用后,该患者接受了世界首例人体采用这一测试药物的治疗。


该患者是英国第一位参与该研究的病人,这一全新药物也是第一次用于人体试验。在世界范围内,开展这一研究的仅有 6 个中心。研究结合了具有免疫治疗的药物,免疫治疗使得患者重新获得和增强了免疫系统抵抗癌症的力量。医生们将进一步密切定期监测、评估患者癌细胞消失的持久性。由于这是一项采用了一种全新药物的联合研究,如何利用第一次成功病例的经验帮助未来更多的患者,还需要做更多的研究。癌症是一种非常复杂的疾病,并不是每个患者都会有这样的结果。

克里斯蒂国家医疗研究所拥有大规模、高质量以及专用临床研究环境的临床研究设施,专门开展癌症治疗新方法研究和临床试验,特别是针对患者特征的个性化治疗,也是曼彻斯特癌症研究中心的组成部分,可以同时开展 600 项的临床试验,在这里患者可以参与复杂和早期的临床试验。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1808827, encodeId=f983180882ecc, content=<a href='/topic/show?id=a2578223406' target=_blank style='color:#2F92EE;'>#肺癌病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82234, encryptionId=a2578223406, topicName=肺癌病人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Mon Aug 28 10:07:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968450, encodeId=d8ce1968450f8, content=<a href='/topic/show?id=a57f208660f' target=_blank style='color:#2F92EE;'>#世界首例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20866, encryptionId=a57f208660f, topicName=世界首例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sat Apr 22 23:07:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179707, encodeId=371b1e9707a3, content=怎么跟没说一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f09e1680692, createdName=1de33cf7m09(暂无匿称), createdTime=Tue Mar 14 00:21:35 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179640, encodeId=b48f1e9640f4, content=可以同时开展600项临床实验!厉害????????, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Mon Mar 13 18:16:20 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179578, encodeId=dcbe1e95785d, content=但愿能够取得更大的突破。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotHc7cjrVcIHD9L2n3LzcQo1WSYledtExBOM76QRXV0FrtWOsoLNA9xaJmBjsBFwPvC7fNarGfAg/132, createdBy=531e1939570, createdName=一个尘埃, createdTime=Mon Mar 13 12:28:02 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179568, encodeId=99da1e9568da, content=什么药啊,又没说?, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Mar 13 12:07:43 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179535, encodeId=94af1e9535a7, content=文章真好,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Mar 13 09:18:22 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1808827, encodeId=f983180882ecc, content=<a href='/topic/show?id=a2578223406' target=_blank style='color:#2F92EE;'>#肺癌病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82234, encryptionId=a2578223406, topicName=肺癌病人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Mon Aug 28 10:07:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968450, encodeId=d8ce1968450f8, content=<a href='/topic/show?id=a57f208660f' target=_blank style='color:#2F92EE;'>#世界首例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20866, encryptionId=a57f208660f, topicName=世界首例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sat Apr 22 23:07:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179707, encodeId=371b1e9707a3, content=怎么跟没说一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f09e1680692, createdName=1de33cf7m09(暂无匿称), createdTime=Tue Mar 14 00:21:35 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179640, encodeId=b48f1e9640f4, content=可以同时开展600项临床实验!厉害????????, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Mon Mar 13 18:16:20 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179578, encodeId=dcbe1e95785d, content=但愿能够取得更大的突破。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotHc7cjrVcIHD9L2n3LzcQo1WSYledtExBOM76QRXV0FrtWOsoLNA9xaJmBjsBFwPvC7fNarGfAg/132, createdBy=531e1939570, createdName=一个尘埃, createdTime=Mon Mar 13 12:28:02 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179568, encodeId=99da1e9568da, content=什么药啊,又没说?, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Mar 13 12:07:43 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179535, encodeId=94af1e9535a7, content=文章真好,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Mar 13 09:18:22 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1808827, encodeId=f983180882ecc, content=<a href='/topic/show?id=a2578223406' target=_blank style='color:#2F92EE;'>#肺癌病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82234, encryptionId=a2578223406, topicName=肺癌病人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Mon Aug 28 10:07:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968450, encodeId=d8ce1968450f8, content=<a href='/topic/show?id=a57f208660f' target=_blank style='color:#2F92EE;'>#世界首例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20866, encryptionId=a57f208660f, topicName=世界首例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sat Apr 22 23:07:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179707, encodeId=371b1e9707a3, content=怎么跟没说一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f09e1680692, createdName=1de33cf7m09(暂无匿称), createdTime=Tue Mar 14 00:21:35 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179640, encodeId=b48f1e9640f4, content=可以同时开展600项临床实验!厉害????????, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Mon Mar 13 18:16:20 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179578, encodeId=dcbe1e95785d, content=但愿能够取得更大的突破。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotHc7cjrVcIHD9L2n3LzcQo1WSYledtExBOM76QRXV0FrtWOsoLNA9xaJmBjsBFwPvC7fNarGfAg/132, createdBy=531e1939570, createdName=一个尘埃, createdTime=Mon Mar 13 12:28:02 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179568, encodeId=99da1e9568da, content=什么药啊,又没说?, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Mar 13 12:07:43 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179535, encodeId=94af1e9535a7, content=文章真好,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Mar 13 09:18:22 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
    2017-03-14 1de33cf7m09(暂无匿称)

    怎么跟没说一样

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1808827, encodeId=f983180882ecc, content=<a href='/topic/show?id=a2578223406' target=_blank style='color:#2F92EE;'>#肺癌病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82234, encryptionId=a2578223406, topicName=肺癌病人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Mon Aug 28 10:07:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968450, encodeId=d8ce1968450f8, content=<a href='/topic/show?id=a57f208660f' target=_blank style='color:#2F92EE;'>#世界首例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20866, encryptionId=a57f208660f, topicName=世界首例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sat Apr 22 23:07:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179707, encodeId=371b1e9707a3, content=怎么跟没说一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f09e1680692, createdName=1de33cf7m09(暂无匿称), createdTime=Tue Mar 14 00:21:35 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179640, encodeId=b48f1e9640f4, content=可以同时开展600项临床实验!厉害????????, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Mon Mar 13 18:16:20 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179578, encodeId=dcbe1e95785d, content=但愿能够取得更大的突破。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotHc7cjrVcIHD9L2n3LzcQo1WSYledtExBOM76QRXV0FrtWOsoLNA9xaJmBjsBFwPvC7fNarGfAg/132, createdBy=531e1939570, createdName=一个尘埃, createdTime=Mon Mar 13 12:28:02 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179568, encodeId=99da1e9568da, content=什么药啊,又没说?, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Mar 13 12:07:43 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179535, encodeId=94af1e9535a7, content=文章真好,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Mar 13 09:18:22 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
    2017-03-13 蔬菜

    可以同时开展600项临床实验!厉害????????

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1808827, encodeId=f983180882ecc, content=<a href='/topic/show?id=a2578223406' target=_blank style='color:#2F92EE;'>#肺癌病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82234, encryptionId=a2578223406, topicName=肺癌病人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Mon Aug 28 10:07:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968450, encodeId=d8ce1968450f8, content=<a href='/topic/show?id=a57f208660f' target=_blank style='color:#2F92EE;'>#世界首例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20866, encryptionId=a57f208660f, topicName=世界首例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sat Apr 22 23:07:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179707, encodeId=371b1e9707a3, content=怎么跟没说一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f09e1680692, createdName=1de33cf7m09(暂无匿称), createdTime=Tue Mar 14 00:21:35 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179640, encodeId=b48f1e9640f4, content=可以同时开展600项临床实验!厉害????????, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Mon Mar 13 18:16:20 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179578, encodeId=dcbe1e95785d, content=但愿能够取得更大的突破。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotHc7cjrVcIHD9L2n3LzcQo1WSYledtExBOM76QRXV0FrtWOsoLNA9xaJmBjsBFwPvC7fNarGfAg/132, createdBy=531e1939570, createdName=一个尘埃, createdTime=Mon Mar 13 12:28:02 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179568, encodeId=99da1e9568da, content=什么药啊,又没说?, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Mar 13 12:07:43 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179535, encodeId=94af1e9535a7, content=文章真好,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Mar 13 09:18:22 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
    2017-03-13 一个尘埃

    但愿能够取得更大的突破。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1808827, encodeId=f983180882ecc, content=<a href='/topic/show?id=a2578223406' target=_blank style='color:#2F92EE;'>#肺癌病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82234, encryptionId=a2578223406, topicName=肺癌病人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Mon Aug 28 10:07:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968450, encodeId=d8ce1968450f8, content=<a href='/topic/show?id=a57f208660f' target=_blank style='color:#2F92EE;'>#世界首例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20866, encryptionId=a57f208660f, topicName=世界首例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sat Apr 22 23:07:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179707, encodeId=371b1e9707a3, content=怎么跟没说一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f09e1680692, createdName=1de33cf7m09(暂无匿称), createdTime=Tue Mar 14 00:21:35 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179640, encodeId=b48f1e9640f4, content=可以同时开展600项临床实验!厉害????????, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Mon Mar 13 18:16:20 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179578, encodeId=dcbe1e95785d, content=但愿能够取得更大的突破。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotHc7cjrVcIHD9L2n3LzcQo1WSYledtExBOM76QRXV0FrtWOsoLNA9xaJmBjsBFwPvC7fNarGfAg/132, createdBy=531e1939570, createdName=一个尘埃, createdTime=Mon Mar 13 12:28:02 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179568, encodeId=99da1e9568da, content=什么药啊,又没说?, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Mar 13 12:07:43 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179535, encodeId=94af1e9535a7, content=文章真好,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Mar 13 09:18:22 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
    2017-03-13 cqykthl

    什么药啊,又没说?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1808827, encodeId=f983180882ecc, content=<a href='/topic/show?id=a2578223406' target=_blank style='color:#2F92EE;'>#肺癌病人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82234, encryptionId=a2578223406, topicName=肺癌病人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295c372, createdName=chaojitidian, createdTime=Mon Aug 28 10:07:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968450, encodeId=d8ce1968450f8, content=<a href='/topic/show?id=a57f208660f' target=_blank style='color:#2F92EE;'>#世界首例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20866, encryptionId=a57f208660f, topicName=世界首例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sat Apr 22 23:07:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179707, encodeId=371b1e9707a3, content=怎么跟没说一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f09e1680692, createdName=1de33cf7m09(暂无匿称), createdTime=Tue Mar 14 00:21:35 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179640, encodeId=b48f1e9640f4, content=可以同时开展600项临床实验!厉害????????, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aadd1680584, createdName=蔬菜, createdTime=Mon Mar 13 18:16:20 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179578, encodeId=dcbe1e95785d, content=但愿能够取得更大的突破。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eotHc7cjrVcIHD9L2n3LzcQo1WSYledtExBOM76QRXV0FrtWOsoLNA9xaJmBjsBFwPvC7fNarGfAg/132, createdBy=531e1939570, createdName=一个尘埃, createdTime=Mon Mar 13 12:28:02 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179568, encodeId=99da1e9568da, content=什么药啊,又没说?, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Mar 13 12:07:43 CST 2017, time=2017-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=179535, encodeId=94af1e9535a7, content=文章真好,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Mar 13 09:18:22 CST 2017, time=2017-03-13, status=1, ipAttribution=)]
    2017-03-13 1e10c84am36(暂无匿称)

    文章真好,值得分享

    0

相关资讯

Plos One:中国肺癌筛查的影响

目前,中国有一半以上的男性是正在吸烟者,来自西方国家的证据告诉我们,随着中国人口老龄化,将会出现前所未有的人群数是因为吸烟导致的死亡。近期,一项发表在杂志PLos one上的研究使用中国肺癌政策模型(LCPM)模拟基于计算机断层扫描(CT)的肺癌筛查的效果,并将之与2015年由中国专家组发布的筛查指南(对美国医疗保险和医疗补助服务中心(CMS)开发的版本的修改)进行比较。中国LCPM可以预测与吸烟

盘点:2月肺癌相关研究新动向

肺癌是我国的头号癌症杀手。靶向药物出现以来,随着时间的推移,肺癌患者不可避免地出现了耐药、疾病进展等情况,迫切需要新型药物延长生命。2月份刚过,让我们来看看与肺癌相关的研究成果,与大家一起学习。【1】Cancer Res:揭示肺癌成功转移到大脑中的分子机制 日前,一项刊登在国际杂志Cancer Research上的题为“Extracellular matrix receptor ex

未来5年10大抗肺癌药物

肺癌是最常见的癌症之一,也是最容易受到环境因素影响而发病的癌症之一,由于最近来我国空气质量状况有下降的趋势,与之对应的是肺癌的发病率和死亡率却是水涨船高,在“肺癌治疗药物的过去、现在与未来”一文中,笔者概述了肺癌药物发展的现状,今日就对现在目前市场上已经上市或者即将上市的药物逐个进行盘点,其中的排名只是一家之言,这一排名不是按照销售状况而言的,毕竟大多数药物可以治疗多种癌症,其销售来源是有多种适应

帮你认识肺癌的各个阶段

肺癌有两种主要类型:非小细胞肺癌和小细胞肺癌。每个都有自己的分期系统,用以确定癌症扩散的程度的过程。分期帮助医生预测发展趋势并制定最好的治疗计划。  本文内容:  1.了解肺癌的各个阶段  2.症状和筛查  3.诊断和治疗了解肺癌的各个阶段  两种主要类型的肺癌都有自己的分期系统。  非小细胞肺癌:  根据美国癌症协会(ACS),非小细胞肺癌(NSCLC)占肺癌病例的约80%。NSCLC的三个

Cancer Res:揭示肺癌成功转移到大脑中的分子机制

每年因肺癌死亡的人要远远多于因乳腺癌、结肠癌以及前列腺癌死亡的人数,肺癌的一种特殊致死性形式是肺腺癌(LUAD),其影响着吸烟和非吸烟人群的健康,在很多被诊断为肺腺癌的患者中,其机体中的肿瘤细胞已经扩散到了大脑中,这样就会明显降低患者的生活质量以及生存率。 日前,一项刊登在国际杂志

新一代靶向药物在中国获批 肺癌患者迎来新希望

勃林格殷格翰中国总部 27 日在上海宣布,第二代 EGFR 靶向药物阿法替尼已在国内获批,为中国的肺癌患者带来了新的希望。肺癌是中国最常见的恶性肿瘤之一,每年新增肺癌病人约 60 万,是癌症死亡原因之首。随着肺癌治疗方面的研究进展,已发现对于具有某种基因突变的肺癌患者,靶向治疗与化疗相比会使患者获益更多。在中国,非小细胞肺癌患者中最常见的基因突变类型为 EGFR 基因突变,大约占 50%。对于这部